Bhatt D.L., Steg P.G., Miller M., et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine 2019; 380(1): 11-22.
Bonds D.E., Harrington M., Worrall B.B., et al. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Internal Medicine 2014; 174(5): 763-771.
Bosch J., Gerstein H.C., Dagenais G.R., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine 2012; 367(4): 309-318.
Bowman L., Mafham M., Wallendszus K., et al. Effects of n-3 fatty acid supplements in diabetes mellitus. New England Journal of Medicine 2018; 379(16): 1540-1550.
Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 2010; 71(12): 1397-1409.
Galan P., Kesse-Guyot E., Czernichow S., et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010; 341: c6273.
Hu Y., Hu F.B., Manson J.E. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. Journal of the American Heart Association 2019; 8(19): e013543.
Kalstad A.A., Myhre P.L., Laake K., et al. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial. Circulation 2021; 143(6): 528-539.
Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids and cardiovascular events after myocardial infarction. New England Journal of Medicine 2010; 363(21): 2015-2026.
Lespérance F., Frasure-Smith N., St-André E., et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. Journal of Clinical Psychiatry 2011; 72(8): 1054-1062.
Manson J.E., Cook N.R., Lee I.M., et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine 2019; 380(1): 33-44.
Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105(16): 1897-1903.
Nicholls S.J., Lincoff A.M., Garcia M., et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA 2020; 324(22): 2268-2280.
Rauch B., Schiele R., Schneider S., et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122(21): 2152-2159.
Roncaglioni M.C., Tombesi M., Avanzini F., et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. New England Journal of Medicine 2013; 368(19): 1800-1808.
Tanaka K., Ishikawa Y., Yokoyama M., et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 2008; 39(7): 2052-2058.
Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372(9645): 1223-1230.
Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369(9567): 1090-1098.
Zhang Y.P., Miao R., Li Q., et al. Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: a 12-month randomized, double-blind, placebo-controlled trial. Journal of Alzheimer's Disease 2017; 55(2): 497-507.
Zheng J., Huang T., Yu Y., et al. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutrition 2012; 15(4): 725-737.